Login / Register

Username:


Password: [Lost?]



New User? Click here for your FREE subscription



Nurse Practitioner
Nurse Practitioner Nurse Practitioner

Follow Us


NEWS-Line on Twitter NEWS-Line on Facebook NEWS-Line on Google+ NEWS-Line on LinkedIn NEWS-Line on Pinterest


Nurse Practitioner Conferences &
Educational Opportunities




June 23, 2020 - 28, 2020

2020 AANP National Conference

American Association of Nurse Practitioners

More Events

Potent Antimicrobial Found That Shows Promise In Fighting Staph Infections | NEWS-Line for Nurse Practitioner

Potent Antimicrobial Found That Shows Promise In Fighting Staph Infections


Source:

Research led by scientists from McMaster University has yielded a potent antimicrobial that works against the toughest infectious disease strains. The find could be the beginning of developing new therapeutics to combat drug-resistant infections.

The discovery is important as it is directly related to the development of Staphylococcus aureus diseases, known popularly as staph infections, which are the leading cause of the growing global danger of antimicrobial resistance, particularly the Methicillin-resistant (MRSA) strains which are becoming resistant to all current antibiotics.

“This antimicrobial has a very exciting mode of action, kind of like hitting many birds with one stone,” said Eric Brown, senior author and a professor of biochemistry and biomedical sciences at McMaster. “This provides a promising starting point.”

After screening thousands of small molecules, the research team discovered a potent new antimicrobial they are calling MAC-545496 that is active against MRSA. Unlike conventional antibiotics, this new antimicrobial neither kills the staph infection nor halts its growth on its own, so the potential for antimicrobial resistance may be considerably lessened.

MAC-545496 cripples MRSA’s ability to cause infection by diminishing its tolerance to the hostile components of the immune system and blocking the bacterium’s capacity to resist the action of several front-line antibiotics.

To be more specific, the antimicrobial disarms MRSA from an important protein called GraR which enables the staph infection to respond to external threats, and allows the immune system to clear the infection more effectively. It also inhibits the ability of the MRSA to resist treatment by antibiotics.

First author Omar El-Halfawy, a postdoctoral fellow of biochemistry and biomedical sciences at McMaster, added: “We screened about 45,000 different compounds and found this potent bioactive, it’s the needle in the haystack. But, although it will be a long road between this discovery and clinical use, we feel we’re expanding our arsenal for combatting drug-resistant staph infections.”

The study, published today in the journal Nature Chemical Biology, was funded by the Canadian Institutes of Health Research and GlycoNet, the Canadian Glycomics Network which is one of the federally-supported networks of centres of excellence of Canada.

Source:McMaster University

Photo Credit:McMaster University

Pictured:Eric Brown (left), professor of biochemistry and biomedical sciences, and Omar El-Halfawy, a postdoctoral fellow of biochemistry and biomedical sciences, at McMaster University







Share This!


Nurse Practitioner Jobs



NURSE PRACTITIONER - Dermatology

CORE PHYSICIANS
Exeter, New Hampshire

Nurse Practitioner

University of Colorado Denver, Departments of Urology and Obstetrics & Gynecology, Division of Female Pelvic Medicine & Reconstructive Surgery
Aurora and Lone Tree, Colorado

FAMILY NURSE PRACTITIONER or PHYSICIAN ASSISTANT

Karuk Tribe
California

Nurse Practitioner

Oak Valley Hospital
Oakdale, California

Mid-level Provider

Northwest Renal Clinic
Portland, Oregon

Nurse Practitioner

Central West Healthcare
St Louis, Missouri

More Jobs
(Dismiss) Thank you for visiting NEWS-Line! Please sign up, login, or follow us on your favorite social networks
to receive custom tailored eNews, job listings, and educational opportunities for your specific profession.